Ratiometric Fluorescent Probes for Measuring Active Albumin in Liver Disease Patients
Liver diseases, including hepatitis, cirrhosis, and fatty liver disease, pose significant health challenges globally. One of the critical biomarkers for assessing liver function and disease severity is serum albumin. Traditionally, measuring albumin levels involves standard assays that do not distinguish between total and active (or functional) albumin. However, recent advancements in ratiometric fluorescent probes present